Covered recipient · General Payments record
ANNA KIM
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$1,575.78
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $627.85 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $199.54 | 6 |
| ABBVIE INC. | $136.05 | 10 |
| LEO Pharma Inc. | $126.11 | 5 |
| UCB, Inc. | $37.06 | 1 |
| Incyte Corporation | $36.38 | 2 |
| Organon LLC | $27.37 | 1 |
| Lilly USA, LLC | $19.16 | 1 |
| MIMEDX Group, Inc. | $17.64 | 1 |
| Galderma Laboratories, L.P. | $15.08 | 1 |
| Almirall LLC | $13.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.65 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070924 | CMS |
| ABBVIE INC. | $18.97 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070926 | CMS |
| ABBVIE INC. | $0.79 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070928 | CMS |
| ABBVIE INC. | $22.41 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070930 | CMS |
| ABBVIE INC. | $0.81 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070932 | CMS |
| ABBVIE INC. | $25.28 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070934 | CMS |
| ABBVIE INC. | $22.10 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070936 | CMS |
| ABBVIE INC. | $4.45 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070938 | CMS |
| ABBVIE INC. | $20.06 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070940 | CMS |
| ABBVIE INC. | $18.53 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104070942 | CMS |
| Almirall LLC | $13.46 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120638322 | CMS |
| Galderma Laboratories, L.P. | $15.08 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145309098 | CMS |
| GENZYME CORPORATION | $6.20 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140013757 | CMS |
| GENZYME CORPORATION | $42.53 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140013765 | CMS |
| GENZYME CORPORATION | $36.34 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140013767 | CMS |
| GENZYME CORPORATION | $36.19 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140013779 | CMS |
| GENZYME CORPORATION | $42.76 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140013803 | CMS |
| GENZYME CORPORATION | $35.52 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140013815 | CMS |
| Incyte Corporation | $19.49 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141194601 | CMS |
| Incyte Corporation | $16.89 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141306219 | CMS |
| LEO Pharma Inc. | $27.69 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152637791 | CMS |
| LEO Pharma Inc. | $24.67 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152637793 | CMS |
| LEO Pharma Inc. | $21.94 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152637795 | CMS |
| LEO Pharma Inc. | $24.26 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152637797 | CMS |
| LEO Pharma Inc. | $27.55 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152637799 | CMS |
| Lilly USA, LLC | $19.16 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136049651 | CMS |
| MIMEDX Group, Inc. | $17.64 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262471 | CMS |
| Organon Llc | $27.37 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136187998 | CMS |
| UCB, Inc. | $37.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143092815 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.